270 related articles for article (PubMed ID: 17009316)
1. Protein-protein interactions as targets for small molecule drug discovery.
Fry DC
Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting protein-protein interactions using designed molecules.
Zhao L; Chmielewski J
Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
[TBL] [Abstract][Full Text] [Related]
4. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
Buchwald P
IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
[TBL] [Abstract][Full Text] [Related]
6. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
7. Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I).
Morelli X; Bourgeas R; Roche P
Curr Opin Chem Biol; 2011 Aug; 15(4):475-81. PubMed ID: 21684802
[TBL] [Abstract][Full Text] [Related]
8. Strategies for targeting protein-protein interactions with synthetic agents.
Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
[TBL] [Abstract][Full Text] [Related]
9. Autoinhibited proteins as promising drug targets.
Peterson JR; Golemis EA
J Cell Biochem; 2004 Sep; 93(1):68-73. PubMed ID: 15352163
[TBL] [Abstract][Full Text] [Related]
10. A large-scale computational approach to drug repositioning.
Li YY; An J; Jones SJ
Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
[TBL] [Abstract][Full Text] [Related]
11. Between a rock and a hard place?
Whitty A; Kumaravel G
Nat Chem Biol; 2006 Mar; 2(3):112-8. PubMed ID: 16484997
[TBL] [Abstract][Full Text] [Related]
12. Structure-based maximal affinity model predicts small-molecule druggability.
Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
[TBL] [Abstract][Full Text] [Related]
13. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
14. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
15. Structural genomics and drug discovery: all in the family.
Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
[TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
17. Modulation of biomolecular interactions with complex-binding small molecules.
Cai Z; Greene MI; Berezov A
Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
[TBL] [Abstract][Full Text] [Related]
18. Rational drug design via intrinsically disordered protein.
Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
[TBL] [Abstract][Full Text] [Related]
19. Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry.
Fry DC
Curr Protein Pept Sci; 2008 Jun; 9(3):240-7. PubMed ID: 18537679
[TBL] [Abstract][Full Text] [Related]
20. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly.
Erlanson DA; Hansen SK
Curr Opin Chem Biol; 2004 Aug; 8(4):399-406. PubMed ID: 15288250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]